Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 14

1.

Treatment and prevention of pouchitis after ileal pouch-anal anastomosis for chronic ulcerative colitis.

Holubar SD, Cima RR, Sandborn WJ, Pardi DS.

Cochrane Database Syst Rev. 2010 Jun 16;(6):CD001176. doi: 10.1002/14651858.CD001176.pub2. Review. Update in: Cochrane Database Syst Rev. 2015;11:CD001176.

PMID:
20556748
2.

Probiotics as therapy in gastroenterology: a study of physician opinions and recommendations.

Williams MD, Ha CY, Ciorba MA.

J Clin Gastroenterol. 2010 Oct;44(9):631-6. doi: 10.1097/MCG.0b013e3181d47f5b.

3.

The probiotic preparation, VSL#3 induces remission in patients with mild-to-moderately active ulcerative colitis.

Sood A, Midha V, Makharia GK, Ahuja V, Singal D, Goswami P, Tandon RK.

Clin Gastroenterol Hepatol. 2009 Nov;7(11):1202-9, 1209.e1. doi: 10.1016/j.cgh.2009.07.016. Epub 2009 Jul 22.

PMID:
19631292
4.

Helping patients make informed choices about probiotics: a need for research.

Sharp RR, Achkar JP, Brinich MA, Farrell RM.

Am J Gastroenterol. 2009 Apr;104(4):809-13. doi: 10.1038/ajg.2008.68. Review.

5.

Effect of a probiotic preparation (VSL#3) on induction and maintenance of remission in children with ulcerative colitis.

Miele E, Pascarella F, Giannetti E, Quaglietta L, Baldassano RN, Staiano A.

Am J Gastroenterol. 2009 Feb;104(2):437-43. doi: 10.1038/ajg.2008.118. Epub 2009 Jan 20.

PMID:
19174792
6.

Recommendations for probiotic use--2008.

Floch MH, Walker WA, Guandalini S, Hibberd P, Gorbach S, Surawicz C, Sanders ME, Garcia-Tsao G, Quigley EM, Isolauri E, Fedorak RN, Dieleman LA.

J Clin Gastroenterol. 2008 Jul;42 Suppl 2:S104-8. doi: 10.1097/MCG.0b013e31816b903f. Review.

PMID:
18542033
7.

Probiotics in the United States.

Vanderhoof JA, Young R.

Clin Infect Dis. 2008 Feb 1;46 Suppl 2:S67-72; discussion S144-51. doi: 10.1086/523339. Review.

8.

Probiotics for induction of remission in ulcerative colitis.

Mallon P, McKay D, Kirk S, Gardiner K.

Cochrane Database Syst Rev. 2007 Oct 17;(4):CD005573. Review.

PMID:
17943867
9.

Patterns of complementary and alternative medicine (CAM) use in patients with inflammatory bowel disease: perceived stress is a potential indicator for CAM use.

Langhorst J, Anthonisen IB, Steder-Neukamm U, Luedtke R, Spahn G, Michalsen A, Dobos GJ.

Complement Ther Med. 2007 Mar;15(1):30-7. Epub 2006 Jun 27.

PMID:
17352969
10.

Probiotics for maintenance of remission in Crohn's disease.

Rolfe VE, Fortun PJ, Hawkey CJ, Bath-Hextall F.

Cochrane Database Syst Rev. 2006 Oct 18;(4):CD004826. Review.

PMID:
17054217
11.

Probiotic use in clinical practice: what are the risks?

Boyle RJ, Robins-Browne RM, Tang ML.

Am J Clin Nutr. 2006 Jun;83(6):1256-64; quiz 1446-7. Review.

12.

Why patients with inflammatory bowel disease use or do not use complementary and alternative medicine: a Canadian national survey.

Li FX, Verhoef MJ, Best A, Otley A, Hilsden RJ.

Can J Gastroenterol. 2005 Sep;19(9):567-73.

PMID:
16151549
13.

Complementary and alternative medicine use by Canadian patients with inflammatory bowel disease: results from a national survey.

Hilsden RJ, Verhoef MJ, Best A, Pocobelli G.

Am J Gastroenterol. 2003 Jul;98(7):1563-8.

PMID:
12873578
14.

Complementary and alternative medicine use by patients with inflammatory bowel disease: An Internet survey.

Hilsden RJ, Meddings JB, Verhoef MJ.

Can J Gastroenterol. 1999 May;13(4):327-32.

PMID:
10360993
Items per page

Supplemental Content

Write to the Help Desk